Drug profile · INN
gemifloxacin mesylate
GEMIFLOXACIN MESYLATE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
gemifloxacin mesylate (GEMIFLOXACIN MESYLATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN gemifloxacin mesylate
Brand GEMIFLOXACIN MESYLATE
Route ORAL
Formulation TABLET
Frequently asked questions
What is gemifloxacin mesylate?
gemifloxacin mesylate (GEMIFLOXACIN MESYLATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for gemifloxacin mesylate?
GEMIFLOXACIN MESYLATE is a marketed brand name for gemifloxacin mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gemifloxacin mesylate?
gemifloxacin mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.